QUADRANT CAPITAL GROUP LLC - AGIOS PHARMACEUTICALS INC ownership

AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 152 filers reported holding AGIOS PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.86 and the average weighting 0.7%.

Quarter-by-quarter ownership
QUADRANT CAPITAL GROUP LLC ownership history of AGIOS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$2,624
-29.8%
106
-19.7%
0.00%
Q2 2023$3,739
+89.2%
132
+53.5%
0.00%
Q1 2023$1,976
-2.3%
86
+19.4%
0.00%
Q4 2022$2,022
-81.6%
72
-81.1%
0.00%
-100.0%
Q3 2022$11,000
+37.5%
381
+3.8%
0.00%0.0%
Q2 2022$8,000
+700.0%
367
+773.8%
0.00%
Q1 2022$1,0000.0%42
+7.7%
0.00%
Q4 2021$1,000
-75.0%
39
-59.8%
0.00%
-100.0%
Q3 2021$4,000
-20.0%
97
+12.8%
0.00%0.0%
Q2 2021$5,000
+25.0%
860.0%0.00%0.0%
Q1 2021$4,0000.0%860.0%0.00%0.0%
Q4 2020$4,000
+300.0%
86
+168.8%
0.00%
Q3 2020$1,0000.0%32
+68.4%
0.00%
Q2 2020$1,000
-95.2%
19
-96.8%
0.00%
-100.0%
Q1 2020$21,000
-4.5%
589
+24.3%
0.00%
+33.3%
Q4 2019$22,000474
+4209.1%
0.00%
Q2 2019$0
-100.0%
11
-90.5%
0.00%
-100.0%
Q1 2019$7,000116
+625.0%
0.00%
Q4 2015$0
-100.0%
16
-84.0%
0.00%
-100.0%
Q3 2015$5,000
+400.0%
100
+525.0%
0.00%
+200.0%
Q2 2015$1,000160.00%
Other shareholders
AGIOS PHARMACEUTICALS INC shareholders Q3 2015
NameSharesValueWeighting ↓
Flagship Ventures 2007 General Partner LLC 1,930,369$118,428,00083.56%
Third Rock Ventures, LLC 3,070,090$188,350,00021.97%
Opaleye Management Inc. 113,500$6,963,225,0005.43%
BB BIOTECH AG 1,890,521$115,983,0004.72%
Eventide Asset Management 431,600$26,479,0003.70%
Atika Capital Management LLC 54,000$3,313,0002.55%
Cormorant Asset Management, LP 100,000$6,135,0001.26%
BRIDGER MANAGEMENT, LLC 220,099$13,503,0000.92%
Ghost Tree Capital, LLC 20,000$1,227,0000.67%
HAMILTON LANE ADVISORS LLC 27,544$1,690,0000.55%
View complete list of AGIOS PHARMACEUTICALS INC shareholders